GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » UnitedHealth Group Inc (NYSE:UNH) » Definitions » ROE %

UnitedHealth Group (UnitedHealth Group) ROE %

: -6.22% (As of Mar. 2024)
View and export this data going back to 1991. Start your Free Trial

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. UnitedHealth Group's annualized net income for the quarter that ended in Mar. 2024 was $-5,636 Mil. UnitedHealth Group's average Total Stockholders Equity over the quarter that ended in Mar. 2024 was $90,563 Mil. Therefore, UnitedHealth Group's annualized ROE % for the quarter that ended in Mar. 2024 was -6.22%.

The historical rank and industry rank for UnitedHealth Group's ROE % or its related term are showing as below:

UNH' s ROE % Range Over the Past 10 Years
Min: 17.4   Med: 24.78   Max: 26.91
Current: 17.89

During the past 13 years, UnitedHealth Group's highest ROE % was 26.91%. The lowest was 17.40%. And the median was 24.78%.

UNH's ROE % is ranked better than
80% of 20 companies
in the Healthcare Plans industry
Industry Median: 8.89 vs UNH: 17.89

UnitedHealth Group ROE % Historical Data

The historical data trend for UnitedHealth Group's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Array ( [0] => - [1] => - [2] => - [3] => - [4] => - [5] => 25.32 [6] => 25.02 [7] => 25.19 [8] => 26.91 [9] => 26.88 )
UnitedHealth Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE %
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.32 25.02 25.19 26.91 26.88

UnitedHealth Group Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
ROE % Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28.22 26.76 28.01 25.19 -6.22

Competitive Comparison

For the Healthcare Plans subindustry, UnitedHealth Group's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


UnitedHealth Group ROE % Distribution

For the Healthcare Plans industry and Healthcare sector, UnitedHealth Group's ROE % distribution charts can be found below:

* The bar in red indicates where UnitedHealth Group's ROE % falls into.



UnitedHealth Group ROE % Calculation

UnitedHealth Group's annualized ROE % for the fiscal year that ended in Dec. 2023 is calculated as

ROE %=Net Income (A: Dec. 2023 )/( (Total Stockholders Equity (A: Dec. 2022 )+Total Stockholders Equity (A: Dec. 2023 ))/ count )
=22381/( (77772+88756)/ 2 )
=22381/83264
=26.88 %

UnitedHealth Group's annualized ROE % for the quarter that ended in Mar. 2024 is calculated as

ROE %=Net Income (Q: Mar. 2024 )/( (Total Stockholders Equity (Q: Dec. 2023 )+Total Stockholders Equity (Q: Mar. 2024 ))/ count )
=-5636/( (88756+92370)/ 2 )
=-5636/90563
=-6.22 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Mar. 2024) net income data. ROE % is displayed in the 30-year financial page.


UnitedHealth Group  (NYSE:UNH) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Mar. 2024 )
=Net Income/Total Stockholders Equity
=-5636/90563
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-5636 / 399184)*(399184 / 278965)*(278965 / 90563)
=Net Margin %*Asset Turnover*Equity Multiplier
=-1.41 %*1.4309*3.0803
=ROA %*Equity Multiplier
=-2.02 %*3.0803
=-6.22 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Mar. 2024 )
=Net Income/Total Stockholders Equity
=-5636/90563
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-5636 / 4) * (4 / 31724) * (31724 / 399184) * (399184 / 278965) * (278965 / 90563)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= -1409 * 0.0001 * 7.95 % * 1.4309 * 3.0803
=-6.22 %

Note: The net income data used here is four times the quarterly (Mar. 2024) net income data. The Revenue data used here is four times the quarterly (Mar. 2024) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


UnitedHealth Group ROE % Related Terms

Thank you for viewing the detailed overview of UnitedHealth Group's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


UnitedHealth Group (UnitedHealth Group) Business Description

Address
9900 Bren Road East, UnitedHealth Group Center, Minnetonka, MN, USA, 55343
UnitedHealth Group is one of the largest private health insurers, providing medical benefits to about 53 million members globally, including 5 million outside the U.S. as of mid-2023. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Executives
Stephen J Hemsley director, officer: Pres & COO, UnitedHealth Grp 200 WASHINGTON AVE N, SUITE 200, MINNEAPOLIS MN 55401
Andrew Witty director, officer: CEO, UHG C/O UNITEDHEALTH GROUP, 9900 BREN ROAD EAST, MN008-T502, MINNETONKA MN 55343
Charles D. Baker director 311 ARSENAL STREET, WATERTOWN MA 02472
Erin Mcsweeney officer: EVP Chief People Officer EMC CORPORATION, 176 SOUTH STREET, HOPKINTON MA 01748
Kristen Gil director C/O UNITEDHEALTH GROUP, 9900 BREN ROAD EAST, MN008-T502, MINNETONKA MN 55343
Thomas E Roos officer: Chief Accounting Officer C/O UNITEDHEALTH GROUP, 9900 BREN ROAD EAST, MN008-T502, MINNETONKA MN 55343
Dirk C Mcmahon officer: President & CEO, UHC C/O UNITEDHEALTH GROUP, 9900 BREN ROAD EAST, MN008-T502, MINNETONKA MN 55343
John F Rex officer: EVP Chief Financial Officer C/O UNITEDHEALTH GROUP, 9900 BREN ROAD EAST, MN008-T502, MINNETONKA MN 55343
Mcnabb Frederick William Iii director C/O UNITEDHEALTH GROUP, 9900 BREN ROAD EAST, MN008-T502, MINNETONKA MN 55343
Richard T Burke director 3962 TOMAHAWK TRAIL, MEDINA MN 55340
Rupert M Bondy officer: EVP & Chief Legal Officer C/O UNITEDHEALTH GROUP, 9900 BREN ROAD EAST, MN008-T502, MINNETONKA MN 55343
Paul R Garcia director 214 N TRYON STREET, CHARLOTTE NC 28202
Brian R Thompson officer: CEO, UnitedHealthcare C/O UNITEDHEALTH GROUP, 9900 BREN ROAD EAST, MN008-T502, MINNETONKA MN 55343
Timothy Patrick Flynn director JPMORGAN CHASE & CO., 270 PARK AVENUE, NEW YORK NY 10017
Matthew W. Friedrich officer: EVP & Chief Legal Officer COGNIZANT TECHNOLOGY SOLUTIONS CORP., 500 FRANK W. BURR BLVD, TEANECK NJ 07666